Amifostine 200 mg/m2 three times weekly vs Amifostine 200 mg/m2 five times weekly
Salivary flow rate · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head and neck region
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomesNo salivary flow rate data related to the effectiveness of different doses of amifostine were reported.0 studiesNo studies found